Jaguar Health (JAGX) Change in Inventory (2015 - 2026)
Jaguar Health (JAGX) reported Change in Inventory of -$780000.0 for Q1 2026, down 473.21% year-over-year from $209000.0 in Q1 2025, and down 2589.66% quarter-over-quarter from -$29000.0 in Q4 2025.
Jaguar Health (JAGX) Change in Inventory (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 12 years of Change in Inventory data on file, last reported at -$780000.0 in Q1 2026.
- Change in Inventory for Q1 2026 came in at -$780000.0, down 473.21% year-over-year; the trailing twelve-month figure through Mar 2026 was -$735000.0 (down 147.91% YoY), and the FY2025 annual result was $254000.0, down 78.03% from the prior year.
- Change in Inventory declined to -$780000.0 in Q1 2026 per JAGX's latest filing, from -$29000.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $1.9 million in Q2 2022 and troughed at -$780000.0 in Q1 2026.
- A 5-year average of $289352.9 and a median of $118000.0 in 2024 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2023 and 2026: Change in Inventory soared 7645.45% in 2023, then slumped 473.21% in 2026.
- A 5-year view of Change in Inventory shows it stood at $423000.0 in 2022, then surged by 91.49% to $810000.0 in 2023, then slipped by 17.16% to $671000.0 in 2024, then plunged by 104.32% to -$29000.0 in 2025, then sank by 2589.66% to -$780000.0 in 2026.
- Business Quant data shows JAGX's Change in Inventory at -$780000.0 in Q1 2026, -$29000.0 in Q4 2025, and -$91000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | -780,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -780,000.00 |
| Mar 31, 2026 | -780,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Sep 30, 2025 | -91,000.00 |
| Sep 30, 2025 | -91,000.00 |
| Jun 30, 2025 | 165,000.00 |
| Jun 30, 2025 | 165,000.00 |
| Mar 31, 2025 | 209,000.00 |
| Mar 31, 2025 | 209,000.00 |
| Dec 31, 2024 | 671,000.00 |
| Dec 31, 2024 | 671,000.00 |
| Sep 30, 2024 | 118,000.00 |
| Sep 30, 2024 | 118,000.00 |
| Jun 30, 2024 | 536,000.00 |
| Jun 30, 2024 | 536,000.00 |
| Mar 31, 2024 | -169,000.00 |
| Mar 31, 2024 | -169,000.00 |
| Dec 31, 2023 | 810,000.00 |
| Dec 31, 2023 | 810,000.00 |